Metraipolis › archive › dc_4fc0fa9d8ff8

Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of Remyelination — Europe PMC PMID:40924614

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40924614
DOI
10.1021/acschemneuro.5c00519
License (as archived)
solo-consultazione
Archived
2026-11-10T01:25:34.603Z
SHA-256 of the archived text
7c73a7383897c887517effa40d9a0d162d26a54d15724ef03391e489842adc77
Stable URL of this page
https://metraipolis.com/documento/dc_4fc0fa9d8ff8

How to cite

Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of Remyelination — Europe PMC PMID:40924614 — Europe PMC (en), https://europepmc.org/article/MED/40924614 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4fc0fa9d8ff8 (Metraipolis archive dc_4fc0fa9d8ff8, sha256 7c73a7383897c887517effa40d9a0d162d26a54d15724ef03391e489842adc77)
BibTeX
@misc{dc4fc0fa9d8ff8,
  title = {Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of Remyelination — Europe PMC PMID:40924614},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40924614},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4fc0fa9d8ff8; sha256 7c73a7383897c887517effa40d9a0d162d26a54d15724ef03391e489842adc77},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40924614. Agents can read the archived copy with the MCP tool read_document.